Modulatory Effects of CD14+CD16++ Monocytes on CD14++CD16− Monocytes: A Possible Explanation of Monocyte Alterations in Systemic Lupus Erythematosus
Open Access
- 28 August 2014
- journal article
- systemic lupus-erythematosus
- Published by Wiley in Arthritis & Rheumatology
- Vol. 66 (12), 3371-3381
- https://doi.org/10.1002/art.38860
Abstract
Objective In various chronic inflammatory processes, both the proportion and numbers of monocyte subsets are altered. In systemic lupus erythematosus (SLE), this has not been clearly determined. The monocyte subpopulations in patients with SLE, patients with other autoimmune diseases, and healthy controls were evaluated. The effects of nonclassic monocytes and apoptotic cells (ACs) on the differentiation and function of CD14++CD16− monocytes were also studied. Methods Monocyte subpopulations derived from the blood samples of SLE patients (n = 88), patients with other autoimmune diseases (n = 37), and healthy control subjects (n = 61) were separated by fluorescence-activated cell sorting. To evaluate the effect of CD14+CD16++ monocytes and ACs on the differentiation of CD14++CD16− monocytes, we developed a coculture model of highly purified sorted monocyte subpopulations, which were reconstituted with defined proportions of CD14++CD16− and CD14+CD16++ monocytes in the presence or absence of ACs. After differentiation into macrophages, CD3+ lymphocytes were added, and the proliferating cells and CD3+IFNγ+ cells were evaluated. A cytokine bead array panel was used to test the coculture supernatants. Results There was a reduction in CD14+CD16++ monocytes in patients with active SLE. Monocytes from SLE patients had decreased expression of HLA–DR and decreased ability to bind and phagocytize ACs. In healthy controls, but not SLE patients, treatment with macrophages derived from CD14+CD16++ monocytes reduced T cell proliferation and proliferating CD3+IFNγ+ cells and increased the accumulation of tumor necrosis factor α, interleukin-10 (IL-10), and IL-1β. Conclusion Our findings show that CD14+CD16++ monocytes, a population that is reduced and nonfunctional in SLE patients, have modulatory effects on CD14++CD16− monocytes and T cells.Keywords
This publication has 42 references indexed in Scilit:
- Mycobacterium tuberculosis alters the differentiation of monocytes into macrophages in vitroCellular Immunology, 2011
- Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammationCritical Care, 2010
- The transcriptome of human monocyte subsets begins to emergeJournal of Biology, 2009
- The consequences of apoptosis in autoimmunityJournal of Autoimmunity, 2008
- 17β-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytesMolecular and Cellular Endocrinology, 2007
- Monocytes Immunoselected via the Novel Monocyte Specific Molecule, CD300e, Differentiate Into Active Migratory Dendritic CellsJournal of Immunotherapy, 2007
- The CD14+ CD16+ blood monocytes: their role in infection and inflammationJournal of Leukocyte Biology, 2006
- Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cellsJournal of Autoimmunity, 2005
- Correlation of Fc Receptor Expression of Monocytes with Clearance Function by Macrophages in Systemic Lupus erythematosusScandinavian Journal of Immunology, 1998
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992